Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: Evidence of a lack of association in Caucasians and African Americans

Cancer Research

Volumn 58, Issue 1, 1998, Pages 65-70

  Bailey, L Renee ^a   Roodi, Nady ^a   Verrier, Carmel S ^a   Yee, Cindy J ^a   Dupont, William D ^a   Parl, Fritz F ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; BREAST NEOPLASMS; CYTOCHROME P-450 CYP1A1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; POLYMORPHISM, GENETIC;

EID: 0031984229     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Harris, J. R., Lippman, M. E., Veronesi, U., and Willett, W. Medical Progress: Breast cancer. N. Engl. J. Med., 327: 319-328, 1992.
2. Henderson, J. C. Risk factors for breast cancer development. Cancer (Phila.), 71: 2127-2140, 1990.
3. Nakachi, K., Hayashi, S-i., and Kawajiri, K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Res., 53: 2994-2999, 1993.
4. Katoh, T., Inatomi, H., Nagaoka, A., and Sugita, A. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glulathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis (Lond.), 16: 655-657, 1995.
5. Pfohl-Leszkowicz, A., Grosse, Y., Carriere, V., Cugnenc, P-H., Berger, A., Carnot, F., Beaune, P., and Waziers, I. D. High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res., 55: 5611-5616, 1995.
6. Venitt, S. Mechanisms of Carcinogenesis and individual susceptibility to cancer. Clin. Chem., 40: 1421-1425, 1994.
7. Kawajiri, K., Nakachi, K., Imai, K., Shinoda, N., and Watanabe, J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Lett.. 263: 131-133, 1990.
8. Hayashi, S., Watanabe, J., Nakachi, K., and Kawajiri, K. Genetic linkage of lung cancer-associated MspI polymorphism with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem., 110: 407-411, 1991.
9. Crofts, F., Cosma, G. N., Currie, D., Taioli, E., Toniolo, P., and Garte, S. J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis (Lond.), 14: 1729-1731, 1993.
10. Cascorbi, I., Brockmoller, J., and Roots, I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res., 56: 4965-4969, 1996.
11. 462: assessment of a role for the rare allele in carcinogenesis. Cancer Res., 56: 3926-3933, 1996.
12. Cosma, G., Crofts, F., Taioli, E., Toniolo, P., and Garte, S. Relationship between genotype and function of the human CYP1A1 gene. J. Toxicol. Environ. Health., 40: 309-316, 1993.
13. Petersen, D. D., McKinney, C. E., Ikeya, K., Smith, H. H., Bale, A. E., McBride, O. W., and Nebert, D. W. Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP. Am. J. Hum. Genet., 48: 720-725, 1991.
14. Landi, M. T., Bertazzi, P. A., Shields, P. G., Clark, G., Lucier, G. W., Garte, S. J., Cosma, G., and Caporaso, N. E. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics, 4: 242-246, 1994.
15. Vaury, C., Laine, R., Noguiez, P., Coppet, P. D., Jaulin, C., Praz, F., Pompon, D., and Amor-Gueret, M. Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res., 55: 5520-5523, 1995.
16. Shields, P. G., Caporaso, N. E., Faulk, R. T., Sugimura, H., Trivers, G. E., Trump, B. F., Hoover, R. N., Weston, A., and Harris, C. C. Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol. Biomark. Prev., 2: 481-485, 1993.
17. Taioli, E., Crofts, F., Trachman, J., Demopoulos, R., Toniolo, P., and Garte, S. J. A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res., 55: 472-473, 1995.
18. Taioli, E., Trachman, J., Chen, X., Toniolo, P., and Garte, S. J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55: 3757-3758, 1995.
19. Raunio, H., Husgafvel-Pursiainen, K., Anttila, S., Hietanen, E., Hirvonen, A., and Pelkonen, O. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility: a review. Gene (Amst.), 159: 113-121, 1995.
20. Seidegard, J., Pero, R. W., Markowitz, M. M., Roush, G., Miller, D. G., and Beattie, E. J. Isoenzymes of glutathione transferase (class μ) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis (Lond.), 11: 33-36, 1990.
21. Wiencke, J. K., Pemble, S., Ketterer, B., and Kelsey, K. T. Gene deletion of glutathione 5-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomark. Prev., 4: 253-259, 1995.
22. Calef, G., and Russo, J. Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis (Lond.), 14: 483-492, 1993.
23. Huang, Z., Fasco, M. J., Figge, H. L., Keyomarsi, K., and Kaminsky, L. S. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos., 24: 889-905, 1996.
24. Murray, G. I., Foster, C. O., Barnes, T. S., Weaver, R. J., Ewen, S. W. B., Melvin, W. T., and Burke, M. D. Expression of cytochrome P450IA in breast cancer. Br. J. Cancer, 63: 1021-1023, 1991.
25. Howie, A. F., Miller, W. R., Hawkins, R. A., Hutchinson, A. R., and Beckett, G. J. Expression of glutathione 5-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. Br. J. Cancer, 60: 834-837, 1989.
26. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A., Ford, T. D., and Shields, P. G. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55: 3483-3485, 1995.
27. Rebbeck, T. R., Rosvold, E. A., Duggan, D. J., Zhang, J., and Buetow, K. H. Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiol. Biomark. Prev., 3: 511-514, 1994.
28. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res., 56: 2979-2984, 1996.
29. Breslow, N. E., and Day, N. E. The analysis of case-control studies. In: Statistical Methods in Cancer Research, Vol. 1. pp. 122-159, Lyon: IARC Scientific Publications, 1980.
30. Strange, R. C., Fryer, A. A., Matharoo, B., Zhao, L., Broome. J., Campbell, D. A., Jones, P., Pastor, I. J., and Singh, R. V. P. The human glutathione S-transferases: comparison of isoenzyme expression in normal and astrocytoma brain. Biochem. Biophys. Acta, 1139: 222-228, 1992.
31. Harada, S., Misawa, S., Nakamura, T., Tanaka, N., Ueno, E., and Nozoe, M. Detection of GST1 gene deletion by the polymerase chain reaction and its possible correlation with stomach cancer in Japanese. Hum. Genet., 90: 1992.
32. Fryer, A. A., Zhao, L., Alldersea, J., Boggild, M. D., Perrett, C. W., Clayton, R. N., Jones, P. W., and Strange, R. C. The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. Carcinogenesis (Lond.), 14: 563-566, 1993.
33. Elexpuru-Camiruaga, J., Buxton, N., Kandula, V., Dias, P. S., Campbell, D., McIntosh, J., Broome, J., Jones, P., Inskip, A., Alldersea, J., Fryer, A. A., and Strange, R. C. Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome p-450 (CYP2D6) loci. Cancer Res., 55: 4237-4239, 1995.
34. Yengi, L., Inskip, A., Gifford, J., Alldersea, J., Bailey, L., Smith, A., Lear, J. T., Heagerty, A. H., Bowers, B., Hand, P., Haynes, J. D., Jones, P. W., Strange, R. C., and Fryer, A. A. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res., 56: 1974-1977, 1996.
35. Chenevix-Trench, G., Young, J., Coggan, M., and Board, P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis (Lond.), 16: 1655-1657, 1995.
36. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S-I. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis (Lond.), 14: 1085-1089, 1993.
37. Hamada, G. S., Sugimura, H., Suzuki, I., Nagura, K., Kiyokawa, E., Iwase, T., Tanaka, M., Takahashi, T., Watanabe, S., Kino, I., and Tsugane, S. The heme-binding region polymorphism of cytochrome P4501A1 (CYP1A1), rather than Rsa1 polymorphism of 11E1 (CYP11E1), is associated with lung cancer in Rio de Janiero. Cancer Epidemiol. Biomark. Prev., 4: 63-67, 1995.
38. Mohla, S., Sampson, C. C., Kahn, T., Enterline, J. P., Leffall, L., and White, J. Estrogen and progesterone receptors in breast cancer in black Americans. Cancer (Phila.), 50: 552-559, 1982.
39. Ownby, H. E., Frederick, J., Russo, J., Brook, S. C., Swanson, G. M., Heppner, G. H., and Brennan, M. J. Racial differences in breast cancer patients. J. Natl. Cancer Inst., 75: 55-60, 1985.
40. Bain, R. P., Greenberg, R. S., and Whitaker, J. P. Racial differences in survival of women with breast cancer. J. Chronic Dis., 39: 631-642, 1986.
41. Hayashi, S-I., Watanabe, J., and Kawajiri, K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res., 83: 866-870, 1992.
42. Calle, E. E., Miracle-McMahill, H. L., Thun, M. J., and Heath C. W., Jr. Cigarette smoking and risk of fatal breast cancer. Am. J. Epidemiol., 139: 1001-1007, 1994.
43. Palmer, J. R., Rosenberg, L., Clarke, E. A., Stolley, P. D., Warshaur, M. E., Zauber, A. G., and Shapiro, S. Breast cancer and cigarette smoking: a hypothesis. Am. J. Epidemiol., 134: 1-13, 1991.
44. Baron, J. A., LaVecchia, C., and Levi, F. The antiestrogenic effect of cigarette smoking in women. Am. J. Obstet. Gynecol., 162: 502-514, 1990.
45. Davis, B. R., Whitehead, J. K., Gill, M. E., Lee, P. N., Butterworth, A. D., and Roe, J. F. C. Response of rat lung to inhaled tobacco smoke with or without prior exposure to 3,4-benzopyrene (BP) given by intratracheal instillation. Br. J. Cancer, 31: 469-484, 1975.
46. Baron, J. A., Newcomb, P. A., Longnecker, M. P., Mittendorf, R., Storer, B. E., Clapp, R. W., Bogdan, G., and Yuen, J. Cigarette smoking and breast cancer. Cancer Epidemiol. Biomark. Prev., 5: 399-403, 1996.